Trending

herceptin

Roche seeks Kadcyla boost to fend off Herceptin biosimilars

Roche seeks Kadcyla boost to fend off Herceptin biosimilars

As biosimilar competition to Herceptin ramps up, Roche is looking to bolster its position in HER2-positive breast cancer

X

Roche seeks Kadcyla boost to fend off Herceptin biosimilars

https://pharmaphorum.com/news/roche-seeks-new-kadcyla-indication/

Pfizer wins Herceptin biosimilar approval in Europe

Pfizer wins Herceptin biosimilar approval in Europe

European Commission (EC) has approved Pfizer’s Trazimera, for breast and gastric cancer treatment, marking it as pharma’s first

X

Pfizer wins Herceptin biosimilar approval in Europe

https://pharmaphorum.com/news/herceptin-biosimilar-european-approval/

MSD launches first Herceptin biosimilar in UK

MSD launches first Herceptin biosimilar in UK

Ontruzant, the first biosimilar version of Roche’s Herceptin (trastuzumab) in Europe has been launched in the UK by MSD.

X

MSD launches first Herceptin biosimilar in UK

https://pharmaphorum.com/news/msd-launches-first-herceptin-biosimilar-in-uk/

Its Herceptin biosimilar nearing launch, Celltrion begins work on Keytruda copy

Its Herceptin biosimilar nearing launch, Celltrion begins work on Keytruda copy

South Korea’s Celltrion has started work on a biosimilar version of pembrolizumab, Merck & Co’s blockbuster immunotherapy Keytruda.

X

Its Herceptin biosimilar nearing launch, Celltrion begins work on Keytruda copy

https://pharmaphorum.com/news/herceptin-biosimilar-nearing-launch-celltrion-begins-work-keytruda-copy/

Samsung Bioepis files Herceptin biosimilar in EU

Samsung Bioepis files Herceptin biosimilar in EU

South Korean firm trying to copy breast cancer blockbuster.

X

Samsung Bioepis files Herceptin biosimilar in EU

https://pharmaphorum.com/news/samsung-bioepis-files-herceptin-biosimilar-eu/

Mylan and Biocon file Herceptin biosimilar in Europe

Mylan and Biocon file Herceptin biosimilar in Europe

First Herceptin biosimilar filed in EU, companies say.

X

Mylan and Biocon file Herceptin biosimilar in Europe

https://pharmaphorum.com/news/mylan-biocon-file-herceptin-biosimilar-europe/

Eye on ASCO Day 1 – There’s life in the old drugs yet

Eye on ASCO Day 1 – There’s life in the old drugs yet

The American Society of Clinical Oncology meeting, the world’s biggest cancer conference, has kicked off in blazing sunshine

X

Eye on ASCO Day 1 – There’s life in the old drugs yet

https://pharmaphorum.com/views-and-analysis/eye-on-asco-day-1-theres-life-in-the-old-drugs-yet/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com